241Oral metastasis as initial presentation of renal cell carcinoma: a case report with review of literature.2025 · Europe PMC
242Paraneoplastic Neurological Syndromes in Oncology: Clinical Features, Mechanisms, and Educational Perspectives.2025 · Europe PMC
244The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.2025 · Europe PMC
246Circulating tumor DNA as part of the routine work-up for patients with suspected advanced lung cancer.2025 · Europe PMC
247Predicting bevacizumab efficacy: the emerging role of ACTL6B in colorectal cancer.2025 · Europe PMC
248The gut microbiome and gastrointestinal cancers: mechanisms, biomarkers and therapeutic opportunities.2025 · Europe PMC
250Interlaced roles of mitochondrial DNA in colorectal cancer: Liquid-biopsy biomarkers, nuclear mtDNA-driven genomic instability, and mito-encoded micro peptide signaling.2025 · Europe PMC
251OS05.6.A POLYAMINE PATHWAY BLOCKADE SENSITISES MYC-DRIVEN MEDULLOBLASTOMA TO CHEMOTHERAPY2025 · Europe PMC
252Complete remission of advanced MSI-H rectal cancer in a young patient treated with nivolumab: a case report and critical appraisal of the literature.2025 · Europe PMC
253Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling.2025 · Europe PMC
254Exploring the impact of NGS on diagnostics and treatment of sarcoma: insights from real-world data across multiple institutions in Europe.2025 · Europe PMC
255Cytological Features of the Emerging Entity Papillary Renal Neoplasm with Reverse Polarity: A Case Report Highlighting the Relevance of Fine-Needle Aspiration in Renal Masses.2025 · Europe PMC
256Quadruple Primary Malignancies: A Rare Case of Breast, Bladder, Lung, and Laryngeal Cancer.2025 · Europe PMC
258Prognostic role of pretreatment serum α-hydroxybutyrate dehydrogenase in patients with small cell lung cancer.2025 · Europe PMC
259P17.48.B TRANSFORMING MOLECULAR NEUROPATHOLOGY FOR ADULT BRAIN TUMOUR PATIENTS IN THE UK: INSIGHTS FROM THE TESSA JOWELL CENTRE OF EXCELLENCE PROGRAMME (2021-2024)2025 · Europe PMC
260Neoadjuvant chemo-reirradiation followed by resection and intraoperative electron beam radiotherapy: outcomes of multimodality treatment for locally recurrent rectal cancer.2025 · Europe PMC
261Provoking myofibroblast death: Strategies to resolve fibrosis and remodel tumor microenvironment.2025 · Europe PMC
262DKK1 Overexpression in Lung Adenocarcinoma: Prognostic Implications, Immune Microenvironment Correlates, and Regulatory Network Characterization.2025 · Europe PMC
264Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system.2025 · Europe PMC
265DeepCMS: A Feature Selection-Driven Model for Cancer Molecular Subtyping with a Case Study on Testicular Germ Cell Tumors.2025 · Europe PMC
266An evidence-based approach to pericardial synovial sarcoma: a unique case report.2025 · Europe PMC
268Daily iron supplementation for prevention or treatment of moderate iron deficiency anemia in patients with solid neoplasm, undergoing concurrent radiochemotherapy treatment.2025 · Europe PMC
269The role of liquid biopsy in the management of concurrent Hodgkin lymphoma and ovarian carcinoma treated with nivolumab.2025 · Europe PMC
270Bibliometric analysis on the correlation between colorectal cancer and tumor microenvironment [2009-2024].2025 · Europe PMC
271Clinical Presentation and Management of Breast Cancer With Vertebral Metastasis: A Retrospective Cohort Study in Tunisia.2025 · Europe PMC
274Pneumomediastinum Masquerading As Superior Vena Cava Obstruction in a Patient With Metastatic Colorectal Cancer: A Diagnostic Challenge.2025 · Europe PMC
275Efficacy and safety of adjuvant short-course immune checkpoint inhibitors following TACE combined with MWA in patients with BCLC A-B hepatocellular carcinoma: a single-arm, prospective, phase II study protocol.2025 · Europe PMC
276Study protocol of a randomised phase II trial of concurrent stereotactic body radiotherapy with immunotherapy versus immunotherapy alone in patients with 1-5 extracranial melanoma oligometastases (AXIOM).2025 · Europe PMC
277Rare but overlooked: choroidal metastasis as a late manifestation of colon cancer with review of literature.2025 · Europe PMC
278Prognostic Impact of Ground-Glass Opacity in Clinical Stage IA Non-Small Cell Lung Cancer With Interstitial Lung Abnormalities.2025 · Europe PMC
279Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion Recurrence.2025 · Europe PMC
280Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy.2025 · Europe PMC
281Estrogen signaling and senescence-associated secretory phenotype in ovarian cancer: remodeling the tumor immune microenvironment and therapy response2025 · Europe PMC
282SMARCB1-Deficient Renal Medullary Carcinoma: A Case Report Highlighting the Value of History and Race Information.2025 · Europe PMC
283Research status and hotspots of oncology genetic nursing: a bibliometric analysis.2025 · Europe PMC
285Assessment of toxicity in patients with ultra-central thoracic tumours treated with stereotactic body radiotherapy with a dose of 50 Gy in 5 fractions.2025 · Europe PMC
287Patient-Derived Tumour Organoids (PDOs) may help oncologists in clinical practice.2025 · Europe PMC
288Survival of hepatectomy in colorectal cancer patients with ten or more liver metastases: a retrospective cohort study of multidisciplinary treatment.2025 · Europe PMC
289Peritoneal Metastases in Gastrointestinal Malignancies: A Review of the Pathophysiology of Metastasis and the Tumour Microenvironment.2025 · Europe PMC
290JS07.6.A AGE-APPROPRIATE MODELS OF PAEDIATRIC BRAIN TUMOURS REVEAL THE INFLUENCE OF AGE ON TUMOUR-IMMUNE INTERACTION.2025 · Europe PMC
291Correlation of Cell-in-Cell Structure With Prognosis in Solid Tumors-A Meta-Analysis.2025 · Europe PMC
292Family and Physician Perspectives: Unassailable, a p53 and PIK3CA Mutant Glioblastoma in a Child.2025 · Europe PMC
293Global bibliometric analysis of pleural mesothelioma biomarkers (2002-2024): trends and emerging frontiers.2025 · Europe PMC
294Solitary Testicular Metastasis From Prostate Cancer Treated With Orchiectomy: A Rare Case of Isolated Recurrence After Salvage Radiotherapy.2025 · Europe PMC
295Heat Shock Proteins in Gastrointestinal and Lung Neuroendocrine Neoplasm: Diagnostic and Therapeutic Perspectives.2025 · Europe PMC
296ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.2025 · Europe PMC
297LAT1 expression in head and neck cancer: a prognostic biomarker with potential relevance for BNCT.2025 · Europe PMC
298Cancer stage documentation and accuracy: Single-center retrospective study on oropharyngeal cancers.2025 · Europe PMC
299Liquid biopsy- A pivotal test to help navigate clinical decisions at a precision center in India!2025 · Europe PMC
300P03.22.A USE OF POSITRON EMISSION TOMOGRAPHY (PET) IN PATIENTS WITH BRAIN TUMOURS AMONG EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER - BRAIN TUMOUR GROUP (EORTC-BTG) SITES2025 · Europe PMC